Nutex Current Deferred Revenue from 2010 to 2024
| NUTX Stock | USD 34.76 0.54 1.58% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 156.5 K | Current Value 161 K | Quarterly Volatility 365.8 K |
Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 26.3 M, Total Revenue of 129 M or Gross Profit of 54.7 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0037 or PTB Ratio of 1.84. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.
Nutex | Current Deferred Revenue |
Latest Nutex Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Nutex Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Nutex Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Nutex Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 384,290 | |
| Geometric Mean | 159,090 | |
| Coefficient Of Variation | 95.19 | |
| Mean Deviation | 341,550 | |
| Median | 173,919 | |
| Standard Deviation | 365,809 | |
| Sample Variance | 133.8B | |
| Range | 802.1K | |
| R-Value | (0.78) | |
| Mean Square Error | 56.8B | |
| R-Squared | 0.61 | |
| Significance | 0.0006 | |
| Slope | (63,659) | |
| Total Sum of Squares | 1.9T |
Nutex Current Deferred Revenue History
About Nutex Health Financial Statements
Nutex Health investors use historical fundamental indicators, such as Nutex Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 156.5 K | 161 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.